AwardTape · Defense awards · Medical · Diagnostics and lab supplies · N0025921P0399
N0025921P0399: -$26K purchase order to Biomerieux Inc
Biomerieux Inc holds a purchase order from Defense Health Agency with -$26K obligated since Oct 2023 and $0 obligated over its life, against a ceiling of $26K. Latest action Apr 4, 2024.
Reagent and consumables
| PIID | N0025921P0399 |
|---|---|
| Type | purchase order |
| Company | Biomerieux Inc |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY HCD WEST |
| Category | Medical · Diagnostics and lab supplies |
| PSC | 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS |
| NAICS | 325413 IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING |
| Obligated since Oct 2023 | -$26K |
| Total obligated (lifetime) | $0 |
| Ceiling (base and all options) | $26K |
| Base date | Sep 16, 2021 |
| Latest action | Apr 4, 2024 |
| End date | Sep 30, 2022 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Competed under simplified acquisition |
| Place of performance | NC |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial